Cargando…

Immunotherapy vs platinum for advanced or metastatic thymic carcinoma: A protocol for systematic review and meta analysis

BACKGROUND: Thymic carcinoma is a rare malignancy, and platinum-based chemotherapy has not previously been established as a standard treatment for advanced or metastatic thymic carcinoma. With the breakthrough and progress of immunotherapy, the possibility of curing thymic carcinoma has greatly incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Jiekun, Tong, Zhangwei, Zhang, Yannan, Chen, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837854/
https://www.ncbi.nlm.nih.gov/pubmed/33545943
http://dx.doi.org/10.1097/MD.0000000000023802

Ejemplares similares